KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables RefundsShares IssuedShares OutstandingShares Repurchased
Ratios

Sarepta Therapeutics (SRPT) Long-Term Debt Issuances (2017 - 2018)

Historic Long-Term Debt Issuances for Sarepta Therapeutics (SRPT) over the last 4 years, with Q4 2018 value amounting to $18.2 million.

  • Sarepta Therapeutics' Long-Term Debt Issuances fell 9664.13% to $18.2 million in Q4 2018 from the same period last year, while for Dec 2023 it was $18.2 million, marking a year-over-year decrease of 7096.84%. This contributed to the annual value of $1.1 billion for FY2022, which is N/A changed from last year.
  • Latest data reveals that Sarepta Therapeutics reported Long-Term Debt Issuances of $18.2 million as of Q4 2018, which was down 9664.13% from $44.4 million recorded in Q3 2018.
  • Sarepta Therapeutics' Long-Term Debt Issuances' 5-year high stood at $540.4 million during Q4 2017, with a 5-year trough of -$133000.0 in Q3 2015.
  • For the 3-year period, Sarepta Therapeutics' Long-Term Debt Issuances averaged around $110.9 million, with its median value being $44.4 million (2018).
  • Examining YoY changes over the last 5 years, Sarepta Therapeutics' Long-Term Debt Issuances showed a top increase of 9664.13% in 2018 and a maximum decrease of 9664.13% in 2018.
  • Sarepta Therapeutics' Long-Term Debt Issuances (Quarter) stood at $399000.0 in 2015, then surged by 135333.58% to $540.4 million in 2017, then crashed by 96.64% to $18.2 million in 2018.
  • Its Long-Term Debt Issuances stands at $18.2 million for Q4 2018, versus $44.4 million for Q3 2018 and $77.1 million for Q2 2018.